Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.
Saved in:
| Title: | Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. |
|---|---|
| Authors: | Heinemann L; Medical Department A, University Hospital Münster, Münster, Germany., Möllers KM; Medical Department A, University Hospital Münster, Münster, Germany., Ahmed HMM; Medical Department A, University Hospital Münster, Münster, Germany., Wei L; Institute of Medical Informatics, University of Münster, Münster, Germany., Sun K; Medical Department A, University Hospital Münster, Münster, Germany., Nimmagadda SC; Medical Department A, University Hospital Münster, Münster, Germany., Frank D; Medical Department A, University Hospital Münster, Münster, Germany., Baumann A; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Poos AM; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Dugas M; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany., Varghese J; Institute of Medical Informatics, University of Münster, Münster, Germany., Raab MS; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Khandanpour C; Medical Department A, University Hospital Münster, Münster, Germany.; Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Jun 20; Vol. 12, pp. 874325. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35795041 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Heinemann+L%22">Heinemann L</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Möllers+KM%22">Möllers KM</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Ahmed+HMM%22">Ahmed HMM</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Wei+L%22">Wei L</searchLink>; Institute of Medical Informatics, University of Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Sun+K%22">Sun K</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Nimmagadda+SC%22">Nimmagadda SC</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Frank+D%22">Frank D</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Baumann+A%22">Baumann A</searchLink>; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Poos+AM%22">Poos AM</searchLink>; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dugas+M%22">Dugas M</searchLink>; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Varghese+J%22">Varghese J</searchLink>; Institute of Medical Informatics, University of Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Clinical Cooperation Unit (CCU) Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Khandanpour+C%22">Khandanpour C</searchLink>; Medical Department A, University Hospital Münster, Münster, Germany.; Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Jun 20; Vol. 12, pp. 874325. <i>Date of Electronic Publication: </i>2022 Jun 20 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35795041 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2022.874325 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 874325 Titles: – TitleFull: Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Heinemann L – PersonEntity: Name: NameFull: Möllers KM – PersonEntity: Name: NameFull: Ahmed HMM – PersonEntity: Name: NameFull: Wei L – PersonEntity: Name: NameFull: Sun K – PersonEntity: Name: NameFull: Nimmagadda SC – PersonEntity: Name: NameFull: Frank D – PersonEntity: Name: NameFull: Baumann A – PersonEntity: Name: NameFull: Poos AM – PersonEntity: Name: NameFull: Dugas M – PersonEntity: Name: NameFull: Varghese J – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Khandanpour C IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 06 Text: 2022 Jun 20 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |